Innovation Partnership Supports ENT Surgeries
By HospiMedica International staff writers Posted on 20 Jul 2015 |
Image: The Scopis Target Guided Surgery (TGS) system (Photo courtesy of Scopis Medical).
A new collaboration between Smith & Nephew (London, United Kingdom) and Scopis medical (Berlin, Germany) will advance complex advanced ear, nose, and throat (ENT) surgeries.
The partnership involves the integration and compatibility of Smith & Nephew’s ENT product range with the Scopis Target Guided Surgery (TGS) system, and the appointment of Smith & Nephew as exclusive distributor of the Scopis TGS in the United Kingdom, Ireland, and Belgium. The TGS is a “next-generation” solution for navigated functional endoscopic sinus surgery (FESS) that offers surgeons highly advanced image guidance and visualization capabilities in a single system. During surgery, planned pathways are overlaid in real-time onto the endoscopic image, providing the surgeon with an augmented reality.
The analysis and planning in three dimensional (3-D) anatomy in TGS is based on the Building Blocks software, a unique solution that allows analysis and identification of sinus cells in complex patient anatomy, and planning of natural drainage pathways to the sinuses. A special guidance and alarm system assists surgeons to guide endoscopic instruments on the pathways direct to the targets. The hybrid navigation system offers electromagnetic, optical, and hybrid tracking technology in one unit, providing a solution that can be extended to interdisciplinary use in craniomaxillofacial (CMF) surgery and neurosurgery.
“The partnership demonstrates Smith & Nephew’s strategy desire to collaborate with companies sharing the same vision in providing healthcare professionals with innovative ENT technologies,” said Mike Gutteridge, unit director for Smith & Nephew’s European ENT business. “Partnering with manufacturers of complementary devices enables us to present the most complete product portfolio to ENT surgeons, delivering best in class technologies for surgery, patients and payers.”
“The partnership with Smith & Nephew as the exclusive distributor in the UK, Ireland, and Belgium in the ENT market allows us to propose our next-generation solutions for ENT surgery with the most professional expertise and support,” said Bartosz Kosmecki, CEO of Scopis. “Combining the Scopis TGS with Smith & Nephew’s ENT product portfolio extends our current minimal-invasive solutions for an even less invasive chronic sinusitis treatment with benefit for surgeons and patients.”
Related Links:
Smith & Nephew
Scopis Medical
The partnership involves the integration and compatibility of Smith & Nephew’s ENT product range with the Scopis Target Guided Surgery (TGS) system, and the appointment of Smith & Nephew as exclusive distributor of the Scopis TGS in the United Kingdom, Ireland, and Belgium. The TGS is a “next-generation” solution for navigated functional endoscopic sinus surgery (FESS) that offers surgeons highly advanced image guidance and visualization capabilities in a single system. During surgery, planned pathways are overlaid in real-time onto the endoscopic image, providing the surgeon with an augmented reality.
The analysis and planning in three dimensional (3-D) anatomy in TGS is based on the Building Blocks software, a unique solution that allows analysis and identification of sinus cells in complex patient anatomy, and planning of natural drainage pathways to the sinuses. A special guidance and alarm system assists surgeons to guide endoscopic instruments on the pathways direct to the targets. The hybrid navigation system offers electromagnetic, optical, and hybrid tracking technology in one unit, providing a solution that can be extended to interdisciplinary use in craniomaxillofacial (CMF) surgery and neurosurgery.
“The partnership demonstrates Smith & Nephew’s strategy desire to collaborate with companies sharing the same vision in providing healthcare professionals with innovative ENT technologies,” said Mike Gutteridge, unit director for Smith & Nephew’s European ENT business. “Partnering with manufacturers of complementary devices enables us to present the most complete product portfolio to ENT surgeons, delivering best in class technologies for surgery, patients and payers.”
“The partnership with Smith & Nephew as the exclusive distributor in the UK, Ireland, and Belgium in the ENT market allows us to propose our next-generation solutions for ENT surgery with the most professional expertise and support,” said Bartosz Kosmecki, CEO of Scopis. “Combining the Scopis TGS with Smith & Nephew’s ENT product portfolio extends our current minimal-invasive solutions for an even less invasive chronic sinusitis treatment with benefit for surgeons and patients.”
Related Links:
Smith & Nephew
Scopis Medical
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures